This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Remedy Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Rupa Rishikesh Sawant: Innovator in Pharmaceutical Formulations
Introduction
Rupa Rishikesh Sawant is a notable inventor based in Wayland, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. Her innovative work focuses on improving the stability and delivery of glyburide, a medication used to treat diabetes.
Latest Patents
Rupa holds a patent for a low-sorbing glyburide formulation and methods. This patent addresses the challenges associated with the sorption of glyburide to various surfaces, such as delivery tubing and containers. The methods and formulations she developed aim to minimize impurities, reduce drug waste, and ensure a predictable and accurate dose of glyburide. This innovation not only enhances the stability of the product but also reduces costs and the volume of dosing solution required for patient infusion.
Career Highlights
Rupa is currently associated with Remedy Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in creating more effective pharmaceutical solutions that benefit patients and healthcare providers alike.
Collaborations
Rupa collaborates with talented professionals in her field, including Kenny K Tran and Deirdre Lowe. Their combined expertise contributes to the success of their projects and the advancement of pharmaceutical innovations.
Conclusion
Rupa Rishikesh Sawant's contributions to pharmaceutical formulations exemplify the impact of innovative thinking in healthcare. Her patent for a low-sorbing glyburide formulation showcases her commitment to improving medication delivery and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile